Newsroom

2006 News Releases

• National Glaucoma Awareness Month a Good Time to See Your Ophthalmologist
  Those at High Risk or with a Family History Are Urged to Have Annual Exams
  (ATLANTA) Ophthalmologists at Emory Eye Center advise annual eye exams to prevent damage from undiagnosed glaucoma. For those with a family history and over the age of 45, annual check-ups are even more important. January is “Glaucoma Awareness Month,” and ophthalmologists at Emory Eye Center and across the country urge Americans who may be at risk for this potentially blinding disease to get a complete eye examination from an Eye MD.
  December 21, 2006

• Emory Vision's Newest Laser Vision Technology—Eye-Q—Can Perform Fastest Lasik Available in U.S.
  (ATLANTA) Emory Vision, part of the Emory Eye Center and the Emory University School of Medicine, has acquired the newest FDA-approved LASIK technology available in the United States. Emory Vision is a refractive surgery center located on the north side of Atlanta and the only LASIK provider affiliated with Emory Healthcare.
  December 20, 2006

• Emory Eye Center Phsician Receives Achievement Award From the American Academy of Ophthalmology at National Meeting
  (ATLANTA) Emory Eye Center ophthalmologist C. Roberto Bernardino, MD, recently received the Achievement Award from the American Academy of Ophthalmology. The award recognized Dr. Bernardino, an oculoplastics specialist, for contributions to the Academy.
  December 5, 2006

• Emory Eye Center Study Finds Laser Treatment Does Not Prevent Vision Loss for People with Early Age-Related Macular Degeneration
  (ATLANTA) Low-intensity laser treatment, thought to be possibly beneficial in slowing or preventing the loss of vision from age-related macular degeneration (AMD), is ineffective in preventing complications of AMD or loss of vision, according to a study published in the November 2006 journal Ophthalmology.
  November 2, 2006

• New Nationwide Study Will Evaluate Effect of Antioxidants and Fish Oil on Progression of Age-Related Macular Degeneration (AMD)
  Nearly 100 Clinical Centers Are Now Seeking 4,000 Study Participants
  Ages 50 - 85 Who Have AMD
  (ATLANTA) Emory Eye Center along with other eye centers across the country will be a part of The National Institutes of Health (NIH) nationwide study to see if a modified combination of vitamins, minerals, and fish oil can further slow the progression of vision loss from AMD, the leading cause of vision loss in the United States for people over age 60.
  October 12, 2006

• Macular Degeneration Immune Studies at Emory Eye Center Receive $1 Million Grant From Dobbs FoundationNew Researcher Santa Jeremy Ono Will Establish Dobbs Laboratory for AMD
  ATLANTA- Emory Eye Center has been awarded a a $1 million grant from the R. Howard Dobbs, Jr. Foundation. The grant will support the research of Santa Jeremy Ono, PhD, by establishing a new laboratory to investigate the role of immunity in the pathogenesis of age-related macular degeneration (the leading cause of blindness in aged individuals).
  September 21, 2006
  

• Research at Emory Eye Center Contributes to FDA Approval of New Treatment For Wet Age-Related Macular Degeneration
  (ATLANTA) Emory Eye Center retina specialists participated in clinical trials that have concluded that a new drug holds hope in the treatment of age-related macular degeneration (AMD). Clinical trials here at Emory and throughout the country have lead to U.S. Food and Drug Administration (FDA) approval of Lucentis™ (ranbizumab injection), a new intravitreal drug that treats the “wet” type of macular degeneration. The drug is made by Genentech.
  July 25, 2006
  

• Emory Eye Center Researchers Awarded NEI R24 Grant to Study Drug Delivery to the Eye
  ATLANTA - Emory Eye Center's Director of Research Henry F. Edelhauser, PhD, along with a team of co-principal investigators from the Eye Center and three other institutions have been awarded an R-24 grant by the National Eye Institute (NEI) for five years. The direct annual costs will run approximately $1.2 million per year. The grant is only the third R-24 grant awarded by the NEI. The collaboration was formed to improve drug delivery to the posterior segment of the eye. Drug delivery to this target is a significant challenge in the treatment of retinal disorders.
  June 15, 2006
  
  

• Emory's RB Pinic Promises a Heartwarming Celebration of Life Along with Colorful, Fun Activities for Children who have Survived RB—Cancer of the Eye
  ( ATLANTA ) The eighth annual RB Picnic , coordinated by the Emory Eye Center, will be held from 9 a.m. to 1:30 p.m. Saturday, June 17 , at WD Thompson Park, off Mason Mill Road in Decatur. This very special event promises a day of fun and celebration for both the young patients and their families who have faced this formerly fatal childhood cancer of the eye called retinoblastoma.
  May 24, 2006

• ALERT: Emory Eye Center Advises Disposing of Implicated Contact Lens Solution Following Five Cases of Fusarium Keratitus
  ATLANTA— The FDA and CDC have issued an alert concerning soft contact lens-associated corneal infection. According to the report, there is an association with Bausch & Lomb’s ReNu with MoistureLoc solution. The exact cause of the infection is still unknown.
  April 25, 2006

• Emory Eye Center Advises Soft Contact Lens Wearers
  ATLANTA— The FDA and CDC have issued an alert concerning soft contact lens-associated corneal infection. According to the report, there is an association with Bausch & Lomb’s ReNu with MoistureLoc solution. It is the only solution that is implicated. The exact cause of the infection is still unknown.
  April 12, 2006

• New Technology Provides Low Vision Patients With New Options For Vision Assisitance
  ATLANTA --Although getting older doesn't mean you lose your vision, many aging Americans are indeed dealing with some sort of vision disability. Some may develop what practitioners call "low vision," meaning vision that can't be corrected with regular glasses or contact lenses, medicine or surgery. Although this vision loss isn't common, those who do develop it do so as a result of eye diseases and conditions such as macular degeneration, cataract, glaucoma and diabetes. A few develop vision loss after traumatic eye injuries or from birth defects.
  March 29, 2006